Evidence map›Paper›PMID 31348493›Full record

ReviewHuman molecular genetics2019

Diverse and dynamic DNA modifications in brain and diseases.

Matthew J Armstrong, Yulin Jin, Emily G Allen, Peng Jin

Open access · bronzeAbstract readReview
In one paragraph

Review in Human molecular genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. BenchmarkingInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Science advances · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Brominated flame retardants, a cornelian dilemma.Environmental chemistry letters · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. N6-methyladenosine and Neurological Diseases.Molecular neurobiology · 2022
    Review
  14. Review
  15. Article
  16. Review
  17. The roles of epigenetic modifications in neurodegenerative diseases.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Matthew J ArmstrongDepartment of Human Genetics, School of Medicine, Emory University, Atlanta, GA, USA.
Yulin JinDepartment of Human Genetics, School of Medicine, Emory University, Atlanta, GA, USA.
Emily G AllenDepartment of Human Genetics, School of Medicine, Emory University, Atlanta, GA, USA.
Peng JinDepartment of Human Genetics, School of Medicine, Emory University, Atlanta, GA, USA.
National Institute on Aging · USUK Dementia Research Institute · GB

Funding

Molecular Basis of rCGG-Mediated NeurodegenerationR01NS051630 · NINDS · EMORY UNIVERSITY · PI NELSON, DAVID LOREN · 2006 to 2023
$9.8M
Dynamic DNA Modifications in Brain and DiseasesR35NS111602 · NINDS · EMORY UNIVERSITY · PI PENG JIN · 2019 to 2026
$6.5M
Dynamic RNA Modifications in human brain development and autismU01MH116441 · NIMH · EMORY UNIVERSITY · PI JIN, PENG · 2018 to 2022
$4.9M
Translational models of neurodevelopmental epigenetics and disease using human iPSCsP01NS097206 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI HE, CHUAN · 2016 to 2020
$4.3M
Genome-wide Profiling of Brain DNA Hydroxymethylome in Alzheimer’s DiseaseRF1AG052476 · NIA · UNIVERSITY OF FLORIDA · PI BENNETT, DAVID ALAN, JIN, PENG · 2016 to 2019
$4.1M
Computational Prediction and Functional Validation of Novel Epigenetic Risk Loci in Alzheimer's DiseaseR56AG062256 · NIA · EMORY UNIVERSITY · PI JIN, PENG, QIN, ZHAOHUI · 2018 to 2018
$788k
Medical Research Council MR/N026004/1NIA NIH HHS R56 AG062256NIMH NIH HHS U01 MH116441NINDS NIH HHS P01 NS097206NINDS NIH HHS R01 NS051630NINDS NIH HHS R35 NS111602
6 · The paper itself

Abstract

DNA methylation is a class of epigenetic modification essential for coordinating gene expression timing and magnitude throughout normal brain development and for proper brain function following development. Aberrant methylation changes are associated with changes in chromatin architecture, transcriptional alterations and a host of neurological disorders and diseases. This review highlights recent advances in our understanding of the methylome's functionality and covers potential new roles for DNA methylation, their readers, writers, and erasers. Additionally, we examine novel insights into the relationship between the methylome, DNA-protein interactions, and their contribution to neurodegenerative diseases. Lastly, we outline the gaps in our knowledge that will likely be filled through the widespread use of newer technologies that provide greater resolution into how individual cell types are affected by disease and the contribution of each individual modification site to disease pathogenicity.

Indexed as

Epigenesis, GeneticAdenosineAlzheimer DiseaseAnimalsAtaxiaBrainChromatinCytosineDNADNA MethylationHistonesHumansMiceNeurodegenerative DiseasesParkinson DiseaseAdenosineChromatinCytosineDNAHistonesN-methyladenosine

Identifiers

PMID31348493
PMCPMC6872432
OpenAlexW2965256346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.